Ipamorelin
A selective ghrelin receptor agonist developed as a growth hormone secretagogue. Stimulates pulsatile GH release without significant prolactin or cortisol increase. Often used in research alongside CJC-1295.
What does Ipamorelin mean in peptide research?
A selective ghrelin receptor agonist developed as a growth hormone secretagogue. Stimulates pulsatile GH release without significant prolactin or cortisol increase. Often used in research alongside CJC-1295. This term is part of the broader field of peptide research, which encompasses both FDA-approved therapeutic peptides and research-grade compounds used in scientific investigation.
Why this term matters
Understanding Ipamorelin is foundational for anyone reviewing peptide research literature, comparing different research compounds, or following regulatory developments in this field. The term appears across pharmacology textbooks, FDA documentation, and clinical trial reports.
Where to learn more
For deeper context, see our peptide research articles: